Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Growing Demand: The market for over-the-wire micro-guide catheters is witnessing a steady rise in demand due to the increasing prevalence of cardiovascular diseases and the rising adoption of minimally invasive procedures.
Technological Advancements: Continuous technological advancements in micro-guide catheters, such as improvements in material composition, design, and maneuverability, are driving market growth by enhancing procedural efficiency and patient outcomes.
Expanding Applications: The versatility of over-the-wire micro-guide catheters in various interventional procedures, including coronary angioplasty, neurovascular interventions, and peripheral vascular interventions, is expanding their market potential across different medical specialties.
Rising Healthcare Expenditure: The growing healthcare expenditure globally, coupled with increasing investments in healthcare infrastructure and facilities, is fueling the adoption of advanced medical devices like over-the-wire micro-guide catheters.
Market Competition: The market for over-the-wire micro-guide catheters is characterized by intense competition among key players, leading to constant innovations, strategic collaborations, and product launches aimed at gaining a competitive edge and expanding market share.
Regulatory Landscape: Stringent regulatory requirements and approval processes for medical devices pose challenges for market players, but adherence to quality standards is crucial for maintaining consumer trust and market credibility.
Market Consolidation: Mergers and acquisitions are prevalent in the over-the-wire micro-guide catheter market as companies seek to strengthen their product portfolios, expand their geographical presence, and leverage synergies to achieve sustainable growth.
Cost Containment Efforts: Healthcare cost containment efforts by governments and insurers may pose a challenge to market growth, as pricing pressures and reimbursement policies influence purchasing decisions and market dynamics.
Emerging Markets: The market for over-the-wire micro-guide catheters is witnessing significant growth opportunities in emerging markets due to rising healthcare infrastructure development, increasing disposable income levels, and a growing patient pool with unmet medical needs.
Patient Safety and Comfort: Focus on enhancing patient safety and comfort during interventional procedures is driving innovations in over-the-wire micro-guide catheter design, with features aimed at reducing procedural risks and improving patient experience.
Educational Initiatives: Educational initiatives and training programs aimed at healthcare professionals are essential for promoting awareness about the benefits and proper usage of over-the-wire micro-guide catheters, thus driving market growth through increased adoption and procedural expertise.
Over-the-wire Micro-Guide Catheter Market Highlights:
Global Over-The-Wire Micro-Guide Catheter Market Overview
The Over The Wire Micro Guide Catheter Market Size was valued at USD 1.32 Billion in 2023. The Global Over The Wire Micro Guide Catheter industry is projected to grow from USD 1.67 Billion in 2024 to USD 2.45 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 11.67% during the forecast period (2024 - 2032). Over-the-wire micro-guide catheters are in-vitro tests that use antigen-antibody reaction to detect the concentrations of a wide range of biological substances in the blood and other fluids. Over-the-wire micro-guide catheters are extensively used in several areas of pharmaceutical research such as therapeutic drug monitoring, disease diagnosis, clinical pharmacokinetics, and bioequivalence studies in drug discovery, among others.
Growing preference towards minimally invasive surgical procedures, technological advancements in over-the-wire micro-guide catheters, an increasing number of patients suffering from cardiac and neurovascular disorders, rising geriatric population are the major drivers propelling market growth. However, the risk of infections, lack of skilled physicians may constrain the growth of the market.
In February 2024, BIOTRONIK is delighted to introduce the Micro Rx™ catheter, an innovative rapid exchange microcatheter that has been designed to simplify the process of improving guidewire support during percutaneous coronary interventions (PCI). This innovative device, which is exclusively distributed by BIOTRONIK, is produced by IMDS (Interventional Medical Device Solutions). The Micro Rx catheter is the fourth IMDS product that BIOTRONIK has introduced to the United States, resulting in a compelling portfolio of devices that includes NHancer Rx, TrapIT, and ReCross catheters. The Micro Rx catheter is equipped with a reinforced distal shaft that is constructed with a core wire sandwiched between two layers of braids to facilitate optimal push transfer. Additionally, it has a tapered tip with the tiniest leading edge on the market, which provides increased penetration force. Furthermore, it is equipped with a Proximal-End-Stop that has been meticulously designed to facilitate the seamless integration of a guide extension catheter2 to augment its support. The Micro Rx catheter is engineered to prioritize user-friendly intervention, thereby eliminating the necessity for trapping, in recognition of the complexities associated with traversing through challenging vascular anatomies, such as highly stenosed lesions and tortuous vessels. The objective of this method is to reduce the risk of vascular trauma during procedures, thereby reducing the duration of patients' exposure to the catheterization lab environment and the associated risks. It has the capacity to facilitate the successful treatment of more intricate anatomies by non-chronic total occlusion (CTO) operators.
In April 2022, Transit Scientific announced that its XO Cross Support Catheter Platform had been cleared by the FDA for coronary use. The platform is intended to facilitate the exchange of wires, guide and support a guidewire during access to the peripheral or coronary vasculature, and provide a conduit for the delivery of saline solutions or diagnostic contrast agents. Support catheters are employed to assist in the navigation of guidewires through intricate lesions and to facilitate guidewire exchanges during interventional procedures in patients with peripheral or coronary artery disease. Legacy technologies frequently fail to provide adequate guidewire support, are susceptible to kinking, and lack the pushability necessary to effectively navigate severe calcifications and plaque. The XO Cross Support Catheter platform is engineered to provide unprecedented levels of torque response, flexibility, trackability, and pushability, thereby facilitating access to tortuosity and challenging lesions. The non-tapered metal-alloy and polymer construction provides outstanding fatigue resistance against the challenging, intricate lesions that are present in advanced coronary artery disease (CAD), peripheral artery disease (PAD), and critical limb ischemia (CLI).
Over-The-Wire Micro-Guide Catheter Market Trends
Growing preference for minimally invasive surgical procedures. For instance, according to the American Heart Association and Stroke Statistics (2017), about 92.1 million American adults are living with cardiovascular diseases and strokes, and cardiovascular diseases are the significant causes of death globally which accounted for 17.9 million deaths per year in 2015. The number is expected to reach more than 23.6 million by 2030. Additionally, technological advancements in over-the-wire micro-guide catheters, an increasing number of patients suffering from cardiac and neurovascular disorders, and increasing geriatric population are likely to support market growth. On the other hand, risk of infections, lack of skilled physicians is anticipated to hamper the market growth.
Over-The-Wire Micro-Guide Catheter Market Segment Insights
The over-the-wire micro-guide catheter market has been segmented into application and end user.
Over-The-Wire Micro-Guide Catheter Application Insights
Based on application, the market has been segmented into cardiovascular, neurovascular, and others. The cardiovascular segment has been further bifurcated into angiography, angioplasty, peripheral stenting, and others. The neurovascular segment has been further segmented into intracranial aneurysms, percutaneous neuro-interventional procedures, and others.
Over-The-Wire Micro-Guide Catheter End User Insights
By end user, the market has been segmented into hospitals & clinics, ambulatory surgical centers, research & academic institutes, and others. The cardiovascular segment accounted for a market value of USD 59.60 million in 2017.
Over-The-Wire Micro-Guide Catheter Regional Insights
The over-the-wire micro-guide catheter market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is estimated to be the most significant over-the-wire micro-guide catheter market during the forecast period. This is attributed to the increasing occurrences of coronary heart diseases, neurovascular diseases, hypertension, and other metabolic disorders, raising awareness for health, advancement in technologies, good healthcare infrastructure, and favorable reimbursement policies. The European market for the over-the-wire micro-guide catheter is expected to be the second-largest during the forecast period. This can attribute to the rising occurrences of cardiovascular and neurovascular diseases in the geriatric population, government initiatives to boost up clinical research and development, preference of minimally invasive surgery,
Asia-Pacific is estimated to be the fastest-growing market due to the huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, and, favorable health insurance and reimbursement policies drive the over-the-wire micro-guide catheter market. Moreover, in the Asia-Pacific region, China accounted for a market share of 20.20% in 2017. Furthermore, the market in the Middle East & Africa is expected to witness steady growth due to lack of proper healthcare infrastructure, unaffordability of high-cost surgeries, and lack of skilled healthcare professionals
Key Players
The prominent players in the over-the-wire micro-guide catheter market are
- Terumo Corporation
- Medtronic
- Boston Scientific Corporation
- Koninklijke Philips NV
- Teleflex.
Some of the key strategies followed by the players operating in the over-the-wire micro-guide catheter market were continuous innovation and development of the new and better products to beat the opponents and strive in this big market.
Recent Development
In May 2016, Merit Medical Systems signed a distribution deal with PIOLAX Medical Devices, Inc., Japan for a product known as Labyrinth Noah Micro Guide Wire in Japan. With this collaboration, Merit Medical became a global distributor (excluding Japan) of micro-guide wires
InAugust 2017, Koninklijke Philips NV completed the acquisition of The Spectranetics Corporation, which had a considerable market in vascular intervention.
InOctober 2017, Teleflex acquired NeoTract, Inc. (NeoTract), a medical device company that has developed and commercialized the UroLift System, a minimally invasive medical device for treating lower urinary tract symptoms due to benign prostatic hyperplasia or BPH.
Over-The-Wire Micro-Guide Catheter Market Segmentation
Over-the-Wire Micro-Guide Catheter Application Outlook
- Cardiovascular
- Angiography
- Angioplasty
- Peripheral Stenting
- Others
- Neurovascular
- Intracranial Aneurysms
- Percutaneous Neuro interventional Procedures
- Others
- Others
Over-the-Wire Micro-Guide Catheter End User Outlook
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research & Academic Institutes
- Others
Over-the-Wire Micro-Guide Catheter Regional Outlook
- Americas
- North America
- US
- Canada
- South America
- Europe
- Western Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
Available Additional Customizations
Over-the-Wire Micro-Guide Catheter Market segment by Type
Intended Audience
- Medical device manufacturers and distributors
- Government research organizations
- Hospitals and clinics
- Regulatory agencies
- Pharmaceutical companies
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
